Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026)
Bausch & Lomb (BLCO) reported Change in Receivables of -$108.0 million for Q1 2026, down 134.78% on a YoY basis from $310.5 million in Q1 2025, and down 183.08% quarter-over-quarter from $130.0 million in Q4 2025.
Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Change in Receivables for 6 years, with the latest figure at -$108.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 134.78% year-over-year to -$108.0 million; the trailing twelve-month figure through Mar 2026 stood at $86.0 million (down 3.37% YoY), and the FY2025 full-year result was $148.0 million, down 34.8% from the prior year.
- Change in Receivables for Q1 2026 stood at -$108.0 million, down from $130.0 million in the prior quarter.
- The five-year high for Change in Receivables was $130.0 million in Q4 2025, with the low at -$108.0 million in Q1 2026.
- Historically, Change in Receivables has averaged $28.4 million across 5 years, with a median of $27.0 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 2700.0% — and 2024, when it slumped 825.0%.
- Bausch & Lomb's Change in Receivables stood at $27.0 million in 2022, then surged by 44.44% to $39.0 million in 2023, then soared by 205.13% to $119.0 million in 2024, then increased by 9.24% to $130.0 million in 2025, then sank by 183.08% to -$108.0 million in 2026.
- The last three Change in Receivables figures came in at -$108.0 million (Q1 2026), $130.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -25.10 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 146.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 16.86 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 34.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.99 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -152.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | -108.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.00 Mn |
| Mar 31, 2026 | -108.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Dec 31, 2023 | 39.00 Mn |
| Dec 31, 2023 | 39.00 Mn |